Persistent keyword presence across both periods — breast cancer in early projects, broader cancer and genomics research intensifying in recent years with metabolomics added.
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
World-leading research university with deep strengths in life sciences, advanced materials, and machine learning across 758 H2020 projects.
Their core work
The University of Cambridge is one of the world's premier research universities, conducting fundamental and applied research across virtually every scientific discipline. In H2020, it served primarily as a host institution for individual researcher grants (ERC and Marie Curie fellowships) while also contributing deep expertise in life sciences, materials science, data science, and environmental research to collaborative projects. Its real-world output spans from cancer genomics and metabolomics breakthroughs to advanced materials like graphene and organic semiconductors, alongside growing work in machine learning and climate science. With nearly 500 projects as coordinator, Cambridge functions as a magnet for top-tier researchers who bring EU funding to pursue frontier science within its departments.
What they specialise in
Projects like NANOGEN (piezoelectric nanogenerators), NANOSPHERE (photochemistry), and strong recent keyword clusters around graphene, organic semiconductors, and 2D materials.
Machine learning (7 mentions) and data science (4 mentions) dominate recent-period keywords, absent from early period — reflecting a university-wide shift toward computational methods.
Keywords including biotechnology, directed evolution, protein engineering, and projects like METENZ (metalloenzymes for asymmetric C-H activation) show deep biochemistry capability.
Sustainability (5 mentions) and climate change (3 mentions) appear only in recent keywords, signaling a growing institutional commitment to environmental research.
Early-period keywords include brain imaging and MRI, with neurodegeneration appearing in overall top keywords — indicating sustained but not dominant neuroscience activity.
How they've shifted over time
In the early H2020 period (2014–2018), Cambridge's research portfolio centered on biomedical topics — regenerative medicine, breast cancer, type 1 diabetes, brain imaging — alongside archaeology and basic biology (neolithic studies, recombination, genomics). By the later period (2019–2022), the profile shifted markedly toward computational and materials science: machine learning and data science surged to the top, organic semiconductors and graphene became prominent, and sustainability/climate change emerged as new priorities. This evolution mirrors a broader trend of traditional wet-lab and clinical disciplines being augmented — or driven — by computational approaches and a growing institutional emphasis on environmental impact.
Cambridge is rapidly integrating machine learning across its research portfolio while expanding into sustainability and climate science — expect future projects to blend computational methods with life sciences, materials, and environmental applications.
How they like to work
Cambridge is overwhelmingly a project leader: 466 of 758 projects (61%) were coordinated by the university, driven largely by individual ERC grants and Marie Curie fellowships where the host institution is automatically the coordinator. With 2,251 unique consortium partners across 77 countries, Cambridge is a massive network hub rather than a loyal repeat-partner institution. This means working with Cambridge typically means accessing a specific research group or PI rather than a centralized institutional partnership — prospective collaborators should target departments and principal investigators directly.
Cambridge has collaborated with 2,251 distinct partner organizations across 77 countries, making it one of the most connected institutions in H2020. Its network spans all of Europe with significant global reach into North America, Asia, and Africa through research infrastructure and development projects.
What sets them apart
Cambridge's sheer scale — 758 H2020 projects and nearly half a billion euros in EC funding — places it in a class of its own among European universities. Its distinctive strength is disciplinary breadth: few institutions can offer world-class expertise spanning from graphene physics to cancer genomics to archaeological science to machine learning within a single partnership. For consortium builders, Cambridge brings not just scientific credibility and research infrastructure, but also a network effect — partnering with Cambridge connects you indirectly to over 2,000 organizations across 77 countries.
Highlights from their portfolio
- DIGIWHISTEUR 1.6M coordinated project on fiscal transparency and digital governance — unusual for Cambridge, showing social science capacity beyond STEM.
- NANOGENEUR 1.6M coordinated project on polymer-based piezoelectric nanogenerators for energy harvesting — represents Cambridge's strength in translating materials science toward energy applications.
- COMPAREEUR 504K participation in a collaborative platform for detecting foodborne outbreaks — demonstrates Cambridge's ability to contribute to large-scale public health infrastructure projects.